Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial

The Lancet Microbe(2022)

引用 24|浏览15
暂无评分
摘要
The Carol Moss Foundation and City of Hope Integrated Drug Development Venture programme.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要